Quick answer: Anti-CCP is an antibody blood test that helps a clinician assess suspected rheumatoid arthritis alongside joint symptoms, examination and other findings. A positive result supports the diagnosis in the right setting, while a negative result does not exclude disease. Assay units and thresholds vary. QXL must confirm its method and collection instructions before booking in Bengaluru.
Also known as: CCP IgG, ACPA
What is the Anti-CCP Antibody test used for?#
- Persistent inflammatory joint symptoms or clinically apparent synovitis.
- Suspected early rheumatoid arthritis, including selected patients with a negative rheumatoid factor result.
- Further serologic characterisation when the treating clinician considers it useful.
Conditions it helps investigate: Rheumatoid arthritis
What does the test measure?#
- Anti-cyclic citrullinated peptide antibodies: Autoantibodies from the ACPA family associated with rheumatoid arthritis; the assay generation and reporting units matter.
How is it tested?#
General principle: a solid-phase immunoassay uses citrullinated peptide antigens to detect patient autoantibodies, commonly IgG. ELISA and automated immunoassays exist. QXL must confirm assay generation, antibody class, units, reference interval and platform.
Sample and preparation#
Specimen: Venous blood, usually serum; assay-approved plasma may differ. Tube, volume and transport require QXL confirmation.
- Fasting is generally not required for anti-CCP alone.
- Provide the duration and distribution of joint symptoms, previous antibody results and relevant medicines.
- Tell the laboratory about supplements if the selected assay has potential interference.
- Do not stop prescribed arthritis treatment to prepare for this test unless the treating clinician directs it.
| Specimen detail | What to confirm |
|---|---|
| Volume | Pending QXL assay/SOP confirmation. |
| Container | Pending QXL assay/SOP confirmation; use the approved collection kit. |
| Stability | Pending QXL validated time/temperature and transport instructions. |
| Rejection | QXL to confirm assay-specific rejection rules; identifier mismatch, unsuitable container or compromised sample requires laboratory review. |
How are the results interpreted?#
- A positive result supports rheumatoid arthritis in the right clinical setting and can carry prognostic information.
- A negative result does not exclude rheumatoid arthritis, including seronegative disease.
- Interpret the value using the laboratory-specific cut-off and joint findings rather than a universal internet threshold.
Reference interval: Use the QXL report’s assay-specific units, reference interval or decision limit. Age, sex, pregnancy, sampling time and clinical context may change interpretation; there is no universal range for this page.
What are the limitations?#
- Anti-CCP can occasionally be positive in conditions other than rheumatoid arthritis.
- A result alone does not determine disease activity, joint damage or a treatment plan.
- Values from different manufacturers may not be directly interchangeable.
- Persistent swollen joints need clinical review even when serology is negative.
How does it compare with other tests?#
- Anti-CCP and rheumatoid factor detect different antibodies; CRP and ESR are nonspecific inflammation markers.
Notes for referring clinicians#
Provide the diagnostic question, prior results and relevant treatment. Confirm the exact assay, specimen SOP and performing laboratory. Discuss results that conflict with the clinical picture before changing management.
Price, report time and home collection#
- Price: Price requires QXL approval; no unverified price is offered.
- Report time: QXL test-specific turnaround pending confirmation; do not infer from another laboratory.
- Home collection: QXL to confirm test-specific eligibility, collection setting and transport before booking. Ask QXL whether eligible home collection in your Bengaluru pincode is free; do not assume every specimen can be collected at home.
- Processing: QXL to confirm in-house versus referral processing and assay/platform.
- Report review: Proposed reviewer assignment only. Medical review, operations verification and sign-off are pending.
Call +91 9964 639 639 or WhatsApp QXL to confirm the current quote, preparation and collection slot.
Frequently asked questions#
What is anti-CCP?#
It measures antibodies to cyclic citrullinated peptides, a laboratory marker used in assessing rheumatoid arthritis.
Does a positive anti-CCP result prove rheumatoid arthritis?#
It strongly supports the diagnosis in a compatible clinical setting, but interpretation still requires symptoms and examination; occasional positivity occurs in other conditions.
Can rheumatoid arthritis occur if anti-CCP is negative?#
Yes. Some patients have seronegative disease. Ongoing joint swelling deserves specialist assessment regardless of antibody results.
How is it different from rheumatoid factor?#
They detect different autoantibodies. A clinician may use both because their patterns can provide complementary information.
Is it a general arthritis screening test?#
It is intended for a focused clinical assessment, especially inflammatory arthritis. It does not explain every cause of joint pain.
Do I need to fast?#
Not usually for anti-CCP alone. Check whether other ordered investigations have separate preparation requirements.
Should the number be checked repeatedly to monitor therapy?#
Anti-CCP is primarily used for diagnostic and prognostic assessment. Routine disease monitoring usually relies on clinical measures and selected other tests.
Why can two laboratories report different numbers?#
Assay design, units and positivity thresholds vary. Compare the report-specific reference information and seek laboratory advice before comparing values.
Related test guides#
Sources#
- Clinical principles are supported by the cited textbook sections and current primary guidance; actual QXL kit, specimen volume, stability, price, turnaround and availability remain unverified.
Educational information only; not a diagnosis or a substitute for a doctor’s advice.
Medical & Laboratory Disclaimer
Medical information notice: This article is for general educational purposes and does not diagnose disease or replace consultation with a qualified healthcare professional. Test selection, preparation and interpretation should be based on individual clinical circumstances.
Dr. Shantakumar Muruda
MD (Biochemistry), Founder & CEO
QXL Clinical Editorial Commitment: Every health guide, biomarker explanation, and screening schedule published on this portal undergoes rigorous clinical review by qualified MD pathologists and biochemists to ensure adherence to peer-reviewed evidence (ACOG, WHO, ICMR) and laboratory diagnostic accuracy.

